The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4327765 3966140 F 4327765-1 20020101 20030613 20040331 EXP PHBS2003JP06217 NOVARTIS PHARMACEUTICALS CORP. 64 YR F Y 20040331 MD 20030501

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4327765 1004748391 PS GLEEVEC 1 ORAL UNK, Q48H
4327765 1004748392 SS GLEEVEC 1 ORAL 200 MG, BID

Indications of drugs used

Event ID DRUG SEQ INDI PT
4327765 1004748391 GASTROINTESTINAL CARCINOMA

Outcome of event

Event ID OUTC COD
4327765 DE
4327765 HO

Reactions reported

Event ID PT
4327765 ABDOMINAL PAIN
4327765 ABDOMINAL PAIN UPPER
4327765 DIARRHOEA
4327765 LIVER CARCINOMA RUPTURED
4327765 METASTASES TO PERITONEUM
4327765 PERITONITIS
4327765 RASH
4327765 THROMBOCYTOPENIA
4327765 TUMOUR HAEMORRHAGE

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4327765 HP

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4327765 1004748391 20020101
4327765 1004748392 20020301 20020101